FDA product code DDN: Beta-2-Glycoprotein I, Antigen, Antiserum, Control
DDN is the FDA product code for beta-2-glycoprotein i, antigen, antiserum, control. It is a Class I device, regulated under 21 CFR 866.5430 and reviewed by the Immunology panel. Devices under DDN reach the market by 510(k) exempt; FDA lists no cleared 510(k)s for it.
Classification
| Field | Value |
|---|---|
| Device name | Beta-2-Glycoprotein I, Antigen, Antiserum, Control |
| Device class | Class I |
| Regulation | 21 CFR 866.5430 |
| Review panel | IM — Immunology |
| Medical specialty | Immunology |
| Premarket route | 510(k) exempt |
Recalls for DDN devices
FDA recall records list no recalls for product code DDN.
Frequently asked questions
What is FDA product code DDN?
DDN is the FDA product code for beta-2-glycoprotein i, antigen, antiserum, control. It is a Class I device, regulated under 21 CFR 866.5430 and reviewed by the Immunology panel.
What device class is DDN?
Class I, regulation 21 CFR 866.5430. Typical premarket route: 510(k) exempt.
Next steps
- Run an FDA pathway report with predicate devices for product code DDN
- Run a recall and safety report across every DDN manufacturer
- Watch product code DDN for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Immunology product codes · FDA product code lookup · 510(k) database search · 510(k) review times